282
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors

, , , , , , , , , , , , , , , & show all
Pages 218-221 | Received 18 Dec 2015, Accepted 13 Apr 2016, Published online: 17 May 2016
 

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.1080/10428194.2016.1180684.

Funding information

This work was funded by CIHR operating grant [MOP-12863] and the Samuel Waxman Cancer Research Foundation (WHM). The Q-CROC2 clinical trial was financed by Novartis and Roche. DDR is supported by the Cole foundation. LC is the Raymond and Beverly Sackler Scholar and Scholar of the American Society of Hematology. This work was supported by Doris Duke Charitable Foundation Grant [2012070] and the Irma T. Hirschl Career Scientist Award (LC).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.